Astronomers have discovered the farthest star yet, a super-hot, super-bright giant that formed nearly 13 billion years ago at the dawn of the cosmos.
By Marcia Dunn
Astronomers have discovered the farthest star yet, a super-hot, super-bright giant that formed nearly 13 billion years ago at the dawn of the cosmos.
But this luminous blue star is long gone, so massive that it almost certainly exploded into bits just a few million years after emerging. Its swift demise makes it all the more incredible that an international team spotted it with observations by the Hubble Space Telescope. It takes eons for light emitted from distant stars to reach us.
“We’re seeing the star as it was about 12.8 billion years ago, which puts it about 900 million years after the Big Bang,” said astronomer Brian Welch, a doctoral student at Johns Hopkins University and lead author of the study appearing in Wednesday’s journal Nature.
“We definitely just got lucky.”
He nicknamed it Earendel, an Old English name which means morning star or rising light — “a fitting name for a star that we have observed in a time often referred to as `Cosmic Dawn.′ ”
The previous record-holder, Icarus, also a blue supergiant star spotted by Hubble, formed 9.4 billion years ago. That’s more than 4 billion years after the Big Bang.
In both instances, astronomers used a technique known as gravitational lensing to magnify the minuscule starlight. Gravity from clusters of galaxies closer to us — in the foreground — serve as a lens to magnify smaller objects in the background. If not for that, Icarus and Earendel would not have been discernible given their vast distances.
While Hubble has spied galaxies as far away as 300 million to 400 million years of the universe-forming Big Bang, their individual stars are impossible to pick out.
“Usually they’re all smooshed together ... But here, nature has given us this one star — highly, highly magnified, magnified by factors of thousands — so that we can study it,” said NASA astrophysicist Jane Rigby, who took part in the study. “It’s such a gift really from the universe.”
Vinicius Placco of the National Science Foundation’s NOIRlab in Tucson, Arizona, described the findings as “amazing work.” He was not involved in the study.
Placco said based on the Hubble data, Earendel may well have been among the first generation of stars born after the Big Bang. Future observations by the newly launched James Webb Space Telescope should provide more details, he said, and “provide us with another piece of this cosmic puzzle that is the evolution of our universe.”
Current data indicate Earendel was more than 50 times the size of our sun and an estimated 1 million times brighter, outsizing Icarus. Earendel’s small, yet-to-mature home galaxy looked nothing like the pretty spiral galaxies photographed elsewhere by Hubble, according to Welch, but rather “kind of an awkward-looking, clumpy object.” Unlike Earendel, he said, this galaxy probably has survived, although in a different form after merging with other galaxies.
“It's like a little snapshot in amber of the past,” Rigby said.
Earendel may have been the prominent star in a two-star, or binary, system, or even a triple- or quadruple-star system, Welch said. There’s a slight chance it could be a black hole, although the observations gathered in 2016 and 2019 suggest otherwise, he noted.
Regardless of its company, the star lasted barely a few million years before exploding as a supernova that went unobserved as most do, Welch said. The most distant supernova seen by astronomers to date goes back 12 billion years.
The Webb telescope — 100 times more powerful than Hubble — should help clarify how massive and hot the star really is, and reveal more about its parent galaxy.
By studying stars, Rigby said: “We are literally understanding where we came from because we’re made up of some of that stardust.”
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
